A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers

NCT04238364 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: EI-1071
DRUG: Placebo

Sponsor

Elixiron Immunotherapeutics (Hong Kong) Ltd.

Collaborators

[object Object]